Compare Globus Medical Inc. Class A Common Stock (GMED) vs Modine Manufacturing Company (MOD) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

Modine Manufacturing (MOD) trades at $172.57, showing minimal daily change. The stock exhibits a bearish technical signal with strong selling pressure on moving averages, though oscillators are neutral. Fundamentally, the company reported revenue of $2.58 billion in 2025 with a net income of $184 million, but profit margins are expected to compress in 2026. Recent corporate actions include the completion of a $946 million spin-off of its Performance Technologies unit with Gentherm, marking a strategic shift.

The outlook is mixed: strong analyst consensus with a $331.25 price target suggests significant upside, but near-term risks include margin pressure and bearish technical trends. Investment opportunity hinges on successful execution post-spin-off and data center cooling growth, while volatility from restructuring and market sentiment poses risks.